FDA Inspection 1268434 — Ionetix Corporation

Ionetix Corporation — FEI 3017953815

The FDA completed an inspection of Ionetix Corporation on May 1, 2025 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 1, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Citations

IDCFRDescription
1772221 CFR 212.10Lack Adequate Resources, Facilities, Equipment.
1785121 CFR 212.60(c)Analytical methods
1789821 CFR 212.71(c)Correction of problems
2137321 CFR 212.30(b)Equipment procedures
2137621 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination